Overexpression of TIMP3 inhibits discogenic pain by suppressing angiogenesis and the expression of substance P in nucleus pulposus

He,Mingwei; Pang,Jinlei; Sun,Haiyan; Zheng,Guanrong; Lin,Yan; Ge,Weipeng

doi:10.3892/mmr.2020.10922

Overexpression of TIMP3 inhibits discogenic pain by suppressing angiogenesis and the expression of substance P in nucleus pulposus

Authors:
- Mingwei He
- Jinlei Pang
- Haiyan Sun
- Guanrong Zheng
- Yan Lin
- Weipeng Ge
View Affiliations

Affiliations: Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China, Department of Pain, Shengli Oilfield Central Hospital, Dongying, Shandong 257000, P.R. China
Published online on: January 9, 2020 https://doi.org/10.3892/mmr.2020.10922
Pages: 1163-1171
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Approximately 50% of the cases of low back pain (LBP) are attributed to discogenic origin. The causes of discogenic pain are complicated and consist of a complex biochemical cascade. Neovascularization of intervertebral discs (IVDs) is believed to be associated with discogenic pain. The anti‑angiogenesis ability of tissue inhibitor of metalloproteinase‑3 (TIMP3) has been reported in many tumors, yet whether TIMP3 is associated with neovascularization of IVDs remains unknown. In the present study, both in vitro and in vivo models were used to investigate the association between discogenic pain and TIMP3 expression in nucleus pulposus (NP). PCR results demonstrated that inflammation induced downregulation of TIMP3 expression in NP cells. By using an adenovirus system to upregulate TIMP3 expression, the effect of TIMP3 on angiogenesis was measured by endothelial cell migration and tube formation assays. The results demonstrated that overexpression of TIMP3 suppressed angiogenesis in NP without the regulation of vascular endothelial growth factor (VEGF) expression. TNF‑α converting enzyme (TACE) expression was downregulated by TIMP3, thus inhibiting the TACE‑induced activation of TNF‑α in NP cells. Immunohistochemical staining of IVDs also confirmed that TIMP3 inhibited the expression of substance P in NP. Taken together, the present results indicated the expression of TIMP3 in NP may have a key role in the development of discogenic pain.

View Figures

View References

1	Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380:2163–2196. 2012. View Article : Google Scholar : PubMed/NCBI
2	Andersson GB: Epidemiological features of chronic low-back pain. Lancet. 354:581–585. 1999. View Article : Google Scholar : PubMed/NCBI
3	DePalma MJ, Ketchum JM and Saullo T: What is the source of chronic low back pain and does age play a role? Pain Med. 12:224–233. 2011. View Article : Google Scholar : PubMed/NCBI
4	Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G and Bogduk N: The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine (Phila Pa 1976). 20:1878–1883. 1995. View Article : Google Scholar : PubMed/NCBI
5	Wuertz K and Haglund L: Inflammatory mediators in intervertebral disk degeneration and discogenic pain. Global Spine J. 3:175–184. 2013. View Article : Google Scholar : PubMed/NCBI
6	Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV and Anderson DG: The molecular basis of intervertebral disc degeneration. Spine J. 13:318–330. 2013. View Article : Google Scholar : PubMed/NCBI
7	Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M and Boos N: Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann N Y Acad Sci. 1096:44–54. 2007. View Article : Google Scholar : PubMed/NCBI
8	Igarashi T, Kikuchi S, Shubayev V and Myers RR: 2000 Volvo Award winner in basic science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine (Phila Pa 1976). 25:2975–2980. 2000. View Article : Google Scholar : PubMed/NCBI
9	Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF and Nerlich AG: Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine (Phila Pa 1976). 27:2631–2644. 2002. View Article : Google Scholar : PubMed/NCBI
10	Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J and Jayson MI: Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 350:178–181. 1997. View Article : Google Scholar : PubMed/NCBI
11	Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW and Khokha R: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol. 176:721–725. 2006. View Article : Google Scholar : PubMed/NCBI
12	Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC and Khokha R: Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 36:969–977. 2004. View Article : Google Scholar : PubMed/NCBI
13	Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O'Brien JP and Hoyland JA: Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 197:286–292. 2002. View Article : Google Scholar : PubMed/NCBI
14	Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK and Le Maitre CL: Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther. 16:4162014. View Article : Google Scholar : PubMed/NCBI
15	Janssen A, Hoellenriegel J, Fogarasi M, Schrewe H, Seeliger M, Tamm E, Ohlmann A, May CA, Weber BH and Stöhr H: Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3. Invest Ophthalmol Vis Sci. 49:2812–2822. 2008. View Article : Google Scholar : PubMed/NCBI
16	Das AM, Koljenović S, Oude Ophuis CM, van der Klok T, Galjart B, Nigg AL, van Cappellen WA, Noordhoek Hegt V, Dinjens WN, Atmodimedjo PN, et al: Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma. Eur J Cancer. 53:135–143. 2016. View Article : Google Scholar : PubMed/NCBI
17	Välimäki J and Uusitalo H: Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants. Acta Ophthalmol. 93:450–456. 2015. View Article : Google Scholar : PubMed/NCBI
18	Yamauchi K, Inoue G, Koshi T, Yamashita M, Ito T, Suzuki M, Eguchi Y, Orita S, Takaso M, Nakagawa K, et al: Nerve growth factor of cultured medium extracted from human degenerative nucleus pulposus promotes sensory nerve growth and induces substance P in vitro. Spine (Phila Pa 1976). 34:2263–2269. 2009. View Article : Google Scholar : PubMed/NCBI
19	Kuraishi Y, Hirota N, Sato Y, Hino Y, Satoh M and Takagi H: Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res. 325:294–298. 1985. View Article : Google Scholar : PubMed/NCBI
20	Le Maitre CL, Freemont AJ and Hoyland JA: Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 204:47–54. 2004. View Article : Google Scholar : PubMed/NCBI
21	Huang M, Wang HQ, Zhang Q, Yan XD, Hao M and Luo ZJ: Alterations of ADAMTSs and TIMP-3 in human nucleus pulposus cells subjected to compressive load: Implications in the pathogenesis of human intervertebral disc degeneration. J Orthop Res. 30:267–273. 2012. View Article : Google Scholar : PubMed/NCBI
22	Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deakin JA, Buttle DJ, Freemont AJ and Hoyland JA: Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum. 60:482–491. 2009. View Article : Google Scholar : PubMed/NCBI
23	Tsuji T, Chiba K, Imabayashi H, Fujita Y, Hosogane N, Okada Y and Toyama Y: Age-related changes in expression of tissue inhibitor of metalloproteinases-3 associated with transition from the notochordal nucleus pulposus to the fibrocartilaginous nucleus pulposus in rabbit intervertebral disc. Spine (Phila Pa 1976). 32:849–856. 2007. View Article : Google Scholar : PubMed/NCBI
24	Li Y, Li K, Han X, Mao C, Zhang K, Zhao T and Zhao J: The imbalance between TIMP3 and matrix-degrading enzymes plays an important role in intervertebral disc degeneration. Biochem Biophys Res Commun. 469:507–514. 2016. View Article : Google Scholar : PubMed/NCBI
25	Meng F, Zhao Y, Wang B, Li B, Sheng Y, Liu M, Li H and Xiu R: Endothelial cells promote calcification in aortic smooth muscle cells from spontaneously hypertensive rats. Cell Physiol Biochem. 49:2371–2381. 2018. View Article : Google Scholar : PubMed/NCBI
26	Fang JH, Zheng ZY, Liu JY, Xie C, Zhang ZJ and Zhuang SM: Regulatory role of the MicroRNA-29b-IL-6 signaling in the formation of vascular mimicry. Mol Ther Nucleic Acids. 8:90–100. 2017. View Article : Google Scholar : PubMed/NCBI
27	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
28	Chen T, Cheng X, Wang J, Feng X and Zhang L: Time-course investigation of intervertebral disc degeneration induced by different sizes of needle punctures in rat tail disc. Med Sci Monit. 24:6456–6465. 2018. View Article : Google Scholar : PubMed/NCBI
29	Kim JS, Ellman MB, Yan D, An HS, Kc R, Li X, Chen D, Xiao G, Cs-Szabo G, Hoskin DW, et al: Lactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc. J Cell Physiol. 228:1884–1896. 2013. View Article : Google Scholar : PubMed/NCBI
30	Ellman MB, Kim JS, An HS, Chen D, KC R, An J, Dittakavi T, van Wijnen AJ, Cs-Szabo G, Li X, et al: Toll-like receptor adaptor signaling molecule MyD88 on intervertebral disk homeostasis: In vitro, ex vivo studies. Gene. 505:283–290. 2012. View Article : Google Scholar : PubMed/NCBI
31	Le Maitre CL, Freemont AJ and Hoyland JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 7:R732–R745. 2005. View Article : Google Scholar : PubMed/NCBI
32	Le Maitre CL, Hoyland JA and Freemont AJ: Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther. 9:R772007. View Article : Google Scholar : PubMed/NCBI
33	Schaible HG, Schmelz M and Tegeder I: Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev. 58:323–342. 2006. View Article : Google Scholar : PubMed/NCBI
34	Calich AL, Domiciano DS and Fuller R: Osteoarthritis: Can anti-cytokine therapy play a role in treatment? Clin Rheumatol. 29:451–455. 2010. View Article : Google Scholar : PubMed/NCBI
35	Schäfers M, Svensson CI, Sommer C and Sorkin LS: Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci. 23:2517–2521. 2003. View Article : Google Scholar : PubMed/NCBI
36	Olmarker K, Nutu M and Størkson R: Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition. Spine (Phila Pa 1976). 28:1635–1641. 2003. View Article : Google Scholar : PubMed/NCBI
37	Schäfers M and Sommer C: Anticytokine therapy in neuropathic pain management. Expert Rev Neurother. 7:1613–1627. 2007. View Article : Google Scholar : PubMed/NCBI
38	Olmarker K and Larsson K: Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine (Phila Pa 1976). 23:2538–2544. 1998. View Article : Google Scholar : PubMed/NCBI
39	Sainoh T, Orita S, Miyagi M, Inoue G, Kamoda H, Ishikawa T, Yamauchi K, Suzuki M, Sakuma Y, Kubota G, et al: Single intradiscal administration of the tumor necrosis factor-alpha inhibitor, etanercept, for patients with discogenic low back pain. Pain Med. 17:40–45. 2016.PubMed/NCBI
40	Noguchi K and Ruda MA: Gene regulation in an ascending nociceptive pathway: Inflammation-induced increase in preprotachykinin mRNA in rat lamina I spinal projection neurons. J Neurosci. 12:2563–2572. 1992. View Article : Google Scholar : PubMed/NCBI
41	Sun Z, Wan ZY, Guo YS, Wang HQ and Luo ZJ: FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells. Int J Clin Exp Pathol. 6:2376–2385. 2013.PubMed/NCBI
42	Liu ZH, Sun Z, Wang HQ, Ge J, Jiang TS, Chen YF, Ma Y, Wang C, Hu S, Samartzis D and Luo ZJ: FasL expression on human nucleus pulposus cells contributes to the immune privilege of intervertebral disc by interacting with immunocytes. Int J Med Sci. 10:1053–1060. 2013. View Article : Google Scholar : PubMed/NCBI
43	Johnson WE, Caterson B, Eisenstein SM, Hynds DL, Snow DM and Roberts S: Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 46:2658–2664. 2002. View Article : Google Scholar : PubMed/NCBI
44	Cornejo MC, Cho SK, Giannarelli C, Iatridis JC and Purmessur D: Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines. Osteoarthritis Cartilage. 23:487–496. 2015. View Article : Google Scholar : PubMed/NCBI